SCHEMBL25970892

SCHEMBL25970892

C[C@]1(c2cccc(F)c2)OP(Cl)N2CCC[C@H]21

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 3/20 0.38
SLC6A3 Q01959 3/20 0.38
SLC6A2 P23975 2/20 0.38
CHRNA1 P02708 1/20 0.38
CHRNB1 P11230 1/20 0.38
CHRNB2 P17787 1/20 0.38
CHRNB4 P30926 1/20 0.38
CHRNA3 P32297 1/20 0.38
CHRNA4 P43681 1/20 0.38
KDM1A O60341 2/20 0.35
OPRM1 P35372 1/20 0.32
OPRL1 P41146 1/20 0.32
RIPK1 Q13546 1/20 0.32
CCR2 P41597 1/20 0.32
HCRTR2 O43614 1/20 0.32
SLC6A9 P48067 2/20 0.32
CYP2C19 P33261 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25970952 0.87 CHRNA1 (0.32) SLC6A3SLC6A2CHRNA1CHRNB1CHRNB2
SCHEMBL30390498 0.84 CHRM2 (0.36) SLC6A4SLC6A3SLC6A2CHRNB2CHRNB4
SCHEMBL15434592 0.84 CHRM2 (0.36) SLC6A4SLC6A3SLC6A2CHRNB2CHRNB4
SCHEMBL16940167 0.84 CHRM2 (0.36) SLC6A4SLC6A3SLC6A2CHRNB2CHRNB4
SCHEMBL25969376 0.81 SLC18A3 (0.34) SLC6A4SLC6A3SLC6A2OPRL1
SCHEMBL25970852 0.78 HRH3 (0.32) SLC6A3SLC6A2CHRNA1CHRNB1CHRNB2
SCHEMBL20596379 0.77 CHRM2 (0.33) SLC6A4SLC6A3SLC6A2CHRNB2CHRNB4
SCHEMBL20596233 0.77 CHRM2 (0.33) SLC6A4SLC6A3SLC6A2CHRNB2CHRNB4
SCHEMBL25988334 0.75 SLC6A4 (0.38) SLC6A4SLC6A3SLC6A2CHRNA1CHRNB1
SCHEMBL25971151 0.71 CHRM2 (0.33) OPRL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11718638-B2 Compounds, compositions and methods for synthesis WAVE LIFE SCIENCES LTD. (SG) 2023-08-08 US disclosed
US-11718638-B2 Compounds, compositions and methods for synthesis WAVE LIFE SCIENCES LTD. (SG) 2023-08-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11718638-B2 Compounds, compositions and methods for synthesis ALKBH1, DUT, RNGTT SLC6A4 1561/4885SLC6A3 3086/4885SLC6A2 2493/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.